Jordan's Plastic Trash Turned into Art with a Message

Maria Nissan turns plastic waste collected from the streets of Jordan's capital into art in an effort to persuade people against single-use plastics Khalil MAZRAAWI AFP
Maria Nissan turns plastic waste collected from the streets of Jordan's capital into art in an effort to persuade people against single-use plastics Khalil MAZRAAWI AFP
TT

Jordan's Plastic Trash Turned into Art with a Message

Maria Nissan turns plastic waste collected from the streets of Jordan's capital into art in an effort to persuade people against single-use plastics Khalil MAZRAAWI AFP
Maria Nissan turns plastic waste collected from the streets of Jordan's capital into art in an effort to persuade people against single-use plastics Khalil MAZRAAWI AFP

Jordan-based artist Maria Nissan is on a mission: to rid the world of single-use plastics and to raise public awareness about the environmental scourge through eye-catching art.

One of her best-known murals graces the side of a building in the capital Amman, a giant work made from more than 2,000 plastic bottles, almost 1,000 shopping bags and over 150 hookah pipe hoses, AFP said.

A US citizen of Iraqi origin, Nissan said she became enchanted with Amman when she first visited three years ago, but also felt "frustration and anger" at the piles of garbage on the streets and in areas of natural beauty.

"Despite the beauty of the city, walking its streets can be a journey filled with all kinds of trash," the 35-year-old said.

"My eyes cannot turn away from the abundant shiny plastic bags, glass bottles, soda cans, candy bar wrappers," said Nissan, who occasionally sports a dress made from a sturdy blue Ikea bag.

Trained in painting and drawing in the United States and Italy, Nissan decided to collect and repurpose the trash to create art -- often collages themed on women's faces, flowers and Oriental motifs.

Her home, where she has a rooftop workspace under a large canopy, is filled with every imaginable kind of discarded plastic object, from razors and toothbrushes to lighters, pens and plastic spoons.

"Art made of plastic is a concrete and powerful way to raise concerns on environmental issues that affect Jordanians, their children, their communities and natural environments in the kingdom," she said.

- 'Everybody's problem' -
"A bottle littered in a valley will take up to 450 years to decompose," said Nissan, pointing out that the effect is "micro-plastics polluting the soils, water and the wildlife.

"Because plastics are littered indiscriminately in fields and water, livestock and fish feed themselves indirectly with plastic pieces that we will ultimately find on our plates."

Nissan's work has been exhibited in 12 shows in Jordan as well as in Italy and Greece, and features on her Instagram channel @marianissanart, all with the purpose of changing minds and habits.

Jordanians use three billion plastic bags every year, part of the country's annual solid waste load of 2.2 million tons, of which only seven percent is recycled, according to the UN Development Program.

Nissan urges people to avoid buying plastic products and to go shopping with reusable bags, and also advocates a tax on single-use plastics.

"The consequences of single-use plastic pollution are often delayed, and therefore it is difficult to have people feel accountable and responsible for their own acts," she said.

"Plastic comes back to us in one way or another ... It's nobody's responsibility until it becomes everybody's problem."



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”